Actavis PLC (NYSE:ACT)

223.08
Data as of Aug 19
 +5.01 / +2.30%
Today’s Change
130.06
Today|||52-Week Range
230.77
+32.79%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Generic
MARKET CAP
$57.6B

Company Description

Actavis plc operates as an investment holding company. It is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand, brand generic, over-the-counter and biosimilar products. The company was founded on October 1, 2013 and is headquartered in Dublin, Ireland.

Contact Information

Actavis Plc
1 Grand Canal Square
Dublin Dublin 2
P:(951) 493-5300
Investor Relations:
(862) 261-8030

Employees

Shareholders

Other institutional56.76%
Mutual fund holders46.94%
Individual stakeholders0.42%

Top Executives

Brenton L. SaundersPresident, Chief Executive Officer & Director
Robert A. StewartChief Operating Officer
Robert Todd JoyceGlobal Chief Financial Officer
James DareccaChief Accounting Officer & Vice President
William J. MeuryExecutive VP-Commercial North American Brands

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.